Blue Earth Diagnostics to Present Head-to-Head PSMA PET Imaging Data at ASTRO 2026
New research compares Posluma and piflufolastat F 18 detection rates in recurrent prostate cancer and evaluates fluciclovine F 18 PET/CT for brain metastases.
New research compares Posluma and piflufolastat F 18 detection rates in recurrent prostate cancer and evaluates fluciclovine F 18 PET/CT for brain metastases.
A new study shows that the time between a scan and its interpretation continues to climb, driven by a shortage of radiologists and high demand.
Researchers found that neither radiologists nor leading AI models could consistently distinguish real from AI-generated X-rays, highlighting emerging risks in medical imaging and cybersecurity.
The biennial report shows a drop in unfilled positions compared to 2024, though budgeted therapist roles per facility saw a slight dip.